Literature DB >> 8867919

Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice.

M Bernardi1, A Bertolini, K Szczawinska, S Genedani.   

Abstract

The possible effect of ifenprodil--a potent antagonist at the polyamine site of the NMDA receptor complex--on nociceptive threshold and morphine analgesia was investigated in mice. In the hot plate test, the intraperitoneal (i.p.) injection of ifenprodil significantly prolonged the reaction time of mice at the dose of 30 mg/kg, and increased the analgesic effect of morphine. In the phenylquinone writhing test, ifenprodil reduced the number of abdominal constrictions of mice starting from the dose of 2.5 mg/kg i.p., and increased the effect of morphine. The effect of ifenprodil on pain threshold was prevented by naloxone. Moreover, ifenprodil antagonized the pain threshold-reducing effect of alpha-melanocyte-stimulating hormone (0.05 microgram/mouse, intracerebroventricularly). These data show that blockade of the polyamine site of the NMDA receptor complex produces analgesia and increases the analgesic effect of morphine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867919     DOI: 10.1016/0014-2999(95)00778-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Evaluation of morphine analgesia and motor coordination in mice following cortex-specific knockout of the N-methyl-D-aspartate NR1-subunit.

Authors:  Gabriel C Quintero; Reha S Erzurumlu; Anthony L Vaccarino
Journal:  Neurosci Lett       Date:  2008-03-30       Impact factor: 3.046

Review 2.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

3.  Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity.

Authors:  Dmitry S Karlov; Nadezhda S Temnyakova; Dmitry A Vasilenko; Oleg I Barygin; Mikhail Y Dron; Arseniy S Zhigulin; Elena B Averina; Yuri K Grishin; Vladimir V Grigoriev; Alexey V Gabrel'yan; Viktor A Aniol; Natalia V Gulyaeva; Sergey V Osipenko; Yury I Kostyukevich; Vladimir A Palyulin; Petr A Popov; Maxim V Fedorov
Journal:  RSC Med Chem       Date:  2022-06-22

4.  Intracisternal administration of NR2 subunit antagonists attenuates the nociceptive behavior and p-p38 MAPK expression produced by compression of the trigeminal nerve root.

Authors:  Hye J Jeon; Seung R Han; Koang H Lim; Kyoung A Won; Yong C Bae; Dong K Ahn
Journal:  Mol Pain       Date:  2011-06-08       Impact factor: 3.395

5.  Cingulate NMDA NR2B receptors contribute to morphine-induced analgesic tolerance.

Authors:  Shanelle W Ko; Long-Jun Wu; Fanny Shum; Jessica Quan; Min Zhuo
Journal:  Mol Brain       Date:  2008-06-17       Impact factor: 4.041

6.  GluN2B N-methyl-D-aspartate receptor and excitatory amino acid transporter 3 are upregulated in primary sensory neurons after 7 days of morphine administration in rats: implication for opiate-induced hyperalgesia.

Authors:  Kerui Gong; Aditi Bhargava; Luc Jasmin
Journal:  Pain       Date:  2016-01       Impact factor: 7.926

7.  NMDA receptors are expressed in human ovarian cancer tissues and human ovarian cancer cell lines.

Authors:  William G North; Fuli Liu; Ruiyang Tian; Hamza Abbasi; Bonnie Akerman
Journal:  Clin Pharmacol       Date:  2015-10-23

8.  Paeoniflorin inhibits excitatory amino acid agonist-and high-dose morphine-induced nociceptive behavior in mice via modulation of N-methyl-D-aspartate receptors.

Authors:  Yuh-Fung Chen; Ming-Ming Lee; Hsun-Lang Fang; Jhao-Guei Yang; Yu-Chien Chen; Huei-Yann Tsai
Journal:  BMC Complement Altern Med       Date:  2016-07-26       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.